Biocon

Buzzing Stocks: IEX Shares Zoom After Posting 58 Per Cent YOY Growth, Biocon Declines Over 4 Per Cent

Biocon Q1 Net Profit Falls 11% To Rs 148.9 Cr

BY PTI

CCI, Competition commission of India

Economy & Policy

CCI Gives Nod To Edelweiss-Biocon Biologics Deal

BY Press Trust of India

Stock Market Trading Tips: Buy Gujarat Gas, Biocon, Escorts From 1-2 Days Perspective, Says Brokerage Firm Nirmal Bang

Stock Market Trading Tips: Buy Gujarat Gas, Biocon, Escorts From 1-2 Days Perspective, Says Brokerage Firm Nirmal Bang

BY Outlook Business Desk

Shares of the company on Tuesday ended 1.18 per cent down at Rs 234.90 apiece on the BSE.

Biocon Reports Consolidated Net Loss Of Rs 21 Crore In Q3

BY Press Trust of India

Bevacizumab is a medication used to treat a number of types of cancers and a specific eye disease

USFDA Issues CRL For Bevacizumab License Application Moved By Viatris: Biocon

BY PTI

USFDA Issues Complete Response Letter For Proposed Biosimilar Insulin-R: Biocon

USFDA Issues Complete Response Letter For Proposed Biosimilar Insulin-R: Biocon

BY Press Trust of India

Finance Minister Sitharaman, 5 Other Indians Among Forbes’ World’s 100 Most Powerful Women

Finance Minister Sitharaman, 5 Other Indians Among Forbes’ World’s 100 Most Powerful Women

BY Press Trust of India

Advertisement

Company Results

Biocon Q2 Net Falls 11% To Rs 168 Crore; Board Approves Fundraising

BY Press Trust of India

John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Passes Away At 73

John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Passes Away At 73

BY Press Trust of India

Biocon Sells 5.4% Stake In Arm Syngene International

Biocon Sells 5.4% Stake In Arm Syngene International

BY Press Trust of India

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval

BY Press Trust of India

Source: Shutterstock

CBI Arrests Joint Drug Controller For Alleged Bribery To Favour Biocon Biologics' Medicine

BY Press Trust of India

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

BY Press Trust of India

Following this development Biocon shares fell as much as 8 per cent to hit an intraday low of Rs 362

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

BY Outlook Business Desk

Advertisement

Biocon To Launch Drug For COVID-19 Patients

Biocon To Launch Drug For COVID-19 Patients

BY PTI

Betting big on biosimilars

Betting big on biosimilars

BY Himali Patel